AcuCort AB
Stockholm Stock ExchangeTotal Valuation
AcuCort AB carries a market capitalization of 152.39M, placing it among publicly traded companies globally.
| Market Cap | 152.39M |
| Enterprise Value | N/A |
Share Statistics
AcuCort AB currently has 234.44M shares outstanding.
| Shares Outstanding | 234.44M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 229.84, and the price-to-book ratio stands at -1.86.
| PE Ratio | N/A |
| PS Ratio | 229.84 |
| PB Ratio | -1.86 |
| P/TBV Ratio | 8.90 |
| P/FCF Ratio | -16.57 |
| P/OCF Ratio | -9.65 |
Financial Position
AcuCort AB maintains a current ratio of 4.31, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.31 |
| Quick Ratio | 3.99 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -217.54 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -37.04 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
AcuCort AB's stock has declined approximately -8.8359% over the past 52 weeks. The 50-day moving average sits at 0.66, while the 200-day moving average is 0.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | -8.8359% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.66 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, AcuCort AB generated 679,000.00 in revenue and converted that into -26.50M in net income, yielding earnings per share of -0.11. EBITDA reached -26.76M, while operating income came in at -26.76M.
| Revenue | 679,000.00 |
| Gross Profit | 7.43M |
| Operating Income | -26.76M |
| Pretax Income | -26.50M |
| Net Income | -26.50M |
| EBITDA | -26.76M |
| EBIT | -26.76M |
| Earnings Per Share (EPS) | -0.11 |
Balance Sheet
Total book value stands at -83.96M, with working capital of 17.54M providing operational flexibility.
| Cash & Cash Equivalents | 21.15M |
| Total Debt | N/A |
| Net Debt | -21.15M |
| Equity (Book Value) | -83.96M |
| Book Value Per Share | -0.34 |
| Working Capital | 17.54M |
Cash Flow
AcuCort AB produced -16.17M in operating cash flow over the past twelve months. After subtracting -6.75M in capital expenditures, free cash flow totaled -22.92M - equivalent to -0.09 per share.
| Operating Cash Flow | -16.17M |
| Capital Expenditures | -6.75M |
| Free Cash Flow | -22.92M |
| FCF Per Share | -0.09 |
Margins
AcuCort AB operates with a gross margin of 1,094.11, reflecting its pricing power and cost economics. The operating margin of -3,940.80 and net profit margin of -3,902.65 provide insight into operational efficiency.
| Gross Margin | 1,094.11 |
| Operating Margin | -3,940.80 |
| Pretax Margin | -3,902.65 |
| Profit Margin | -3,902.65 |
| EBITDA Margin | -3,940.80 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -3.65 |
| FCF Yield | -6.04 |
Stock Splits
AcuCort AB's most recent stock split took place on October 9, 2023 with a 200:251 split ratio.
| Last Split Date | 10/9/2023 |
| Split Ratio | 200:251 |
Scores
AcuCort AB posts an Altman Z-Score of 4.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.15 |